|
Re: Narmac
|
1
|
Resverlogix Corp.
|
Aug 13, 2024 11:30AM
|
|
Re: Need help here, thanks
|
6
|
Resverlogix Corp.
|
Apr 22, 2021 10:10PM
|
|
Re: need more time, money & partners - FDA response may take until spring - pre market bid/ask..
|
3
|
Resverlogix Corp.
|
Dec 06, 2019 09:06AM
|
|
Re: New Alkaline Phosphate publication from Dr. Kalantar-Zadeh
|
2
|
Resverlogix Corp.
|
Nov 17, 2019 12:39PM
|
|
Re: New Alkaline Phosphate publication from Dr. Kalantar-Zadeh
|
3
|
Resverlogix Corp.
|
Nov 17, 2019 12:57PM
|
|
Re: New Apabetalone Fabry Disease Publication
|
8
|
Resverlogix Corp.
|
Apr 28, 2022 01:06PM
|
|
Re: New Apabetalone Fabry Disease Publication
|
5
|
Resverlogix Corp.
|
Apr 27, 2022 01:10PM
|
|
Re: New Apabetalone Fabry Disease Publication
|
6
|
Resverlogix Corp.
|
Apr 29, 2022 01:28PM
|
|
Re: New but not new Article
|
4
|
Resverlogix Corp.
|
Jun 24, 2021 10:49AM
|
|
Re: New pill from Pfizer....
|
2
|
Resverlogix Corp.
|
Mar 23, 2021 06:00PM
|
|
Re: New SEDAR page
|
1
|
Zenith Epigenetics
|
Aug 08, 2023 12:41PM
|
|
Re: New SEDAR page
|
1
|
Zenith Epigenetics
|
Aug 08, 2023 04:16PM
|
|
Re: New Share Price Contest
|
1
|
Resverlogix Corp.
|
Oct 11, 2019 04:06PM
|
|
Re: New Share Price Contest
|
5
|
Resverlogix Corp.
|
Oct 12, 2019 08:32AM
|
|
Re: New Share Price Contest
|
2
|
Resverlogix Corp.
|
Oct 10, 2019 03:33PM
|
|
Re: New share price contest for end of year 2019
|
3
|
Resverlogix Corp.
|
Nov 19, 2019 06:40PM
|
|
Re: New trial
|
2
|
Zenith Epigenetics
|
May 29, 2021 10:12AM
|
|
Re: New trial
|
4
|
Zenith Epigenetics
|
May 27, 2021 04:13PM
|
|
Re: New-Report of exempt distribution
|
6
|
Resverlogix Corp.
|
Jan 06, 2021 08:53AM
|
|
Re: News out - Dosing of First Cancer Patient with a Combination of ZEN-3694 + Bristol Myers Squibb’s Immune Checkpoint Inhibitor OPDIV
|
3
|
Zenith Epigenetics
|
Feb 25, 2022 11:50AM
|
